Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial. (Q53302870)
Jump to navigation
Jump to search
scientific article published on 26 December 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial. |
scientific article published on 26 December 2013 |
Statements
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial. (English)
Marie Vidailhet
1 reference
Jean-Philippe Azulay
1 reference
Christine Brefel-Courbon
1 reference
Olivier Rascol
1 reference
Fabienne Ory-Magne
1 reference
Anne-Marie Bonnet
Philippe Damier
Estelle Dellapina
Alain Destée
Franck Durif
Monique Galitzky
Thibaud Lebouvier
Claire Thalamas
François Tison
Alexandrine Salis
Agnès Sommet
François Viallet
NS-Park CIC Network
26 December 2013
82
4
300-307